We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

67 hedge funds and large institutions have $281M invested in Fulcrum Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.38% less ownership

Funds ownership: 82.38% → 82% (-0.38%)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 68 → 67 (-1)

11% less capital invested

Capital invested by funds: $317M → $281M (-$36.3M)

Holders
67
Holders Change
-1
Holders Change %
-1.47%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
30
Reduced
16
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$4.43M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.15M
3
PA
Perceptive Advisors
New York
+$2.97M
4
ACM
Altium Capital Management
New York
+$2.16M
5
BlackRock
BlackRock
New York
+$1.71M

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$10.3M
2
BCM
Burrage Capital Management
Massachusetts
-$3.77M
3
IC
Ikarian Capital
Texas
-$2.67M
4
PVI
Pura Vida Investments
New York
-$1.49M
5
SCM
Silverarc Capital Management
Massachusetts
-$1.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
FT
26
Fiduciary Trust
Massachusetts
$1.32M +$10.1K +1,000 +0.8%
N
27
Nuveen
North Carolina
$1.22M -$275K -27,171 -19%
SCM
28
Sio Capital Management
New York
$812K -$1.15M -113,795 -59%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$792K +$261K +25,768 +52%
Morgan Stanley
30
Morgan Stanley
New York
$757K +$45.4K +4,491 +7%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$670K +$220K +21,725 +51%
Charles Schwab
32
Charles Schwab
California
$569K +$108K +10,654 +24%
CTB
33
Country Trust Bank
Illinois
$391K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$320K +$49.3K +4,872 +19%
BFM
35
Boothbay Fund Management
New York
$304K -$221K -21,834 -43%
Goldman Sachs
36
Goldman Sachs
New York
$288K +$132K +13,099 +91%
MA
37
MYDA Advisors
New York
$262K +$93.6K +9,263 +59%
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$241K +$238K +23,531 +4,128%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$236K +$102K +10,120 +82%
BM
40
Brandywine Managers
Delaware
$214K – – –
PP
41
PDT Partners
New York
$189K -$23.7K -2,343 -12%
AllianceBernstein
42
AllianceBernstein
Tennessee
$174K +$9.1K +900 +6%
Two Sigma Investments
43
Two Sigma Investments
New York
$164K +$16.5K +1,632 +12%
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$145K +$139K +13,789 New
Deutsche Bank
45
Deutsche Bank
Germany
$138K +$32.4K +3,203 +32%
JF
46
Jump Financial
Illinois
$133K +$128K +12,699 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$130K +$1.45K +143 +1%
EGM
48
Engineers Gate Manager
New York
$123K -$54.3K -5,371 -31%
ProShare Advisors
49
ProShare Advisors
Maryland
$122K +$117K +11,619 New
Bank of America
50
Bank of America
North Carolina
$108K +$53.3K +5,272 +105%
1
2
3 4

FULC Hedge Fund Activity: Q2 2021 in Review

67 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q2 2021, worth a combined $281M — down 11% from $317M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FULC and 10 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 30 added.

The largest buyer was Cowen and Company, adding an estimated $4.43M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $10.3M sold.

  • 67 institutional investors held Fulcrum Therapeutics (FULC) as of Q2 2021, down from 68 in Q1 2021.
  • Funds reported $281M of Fulcrum Therapeutics stock for Q2 2021, down 11% quarter-over-quarter.
  • 10 funds opened new Fulcrum Therapeutics positions in Q2 2021 and 11 closed out, a net change of -1 holder.
  • The largest Fulcrum Therapeutics buyer in Q2 2021 was Cowen and Company, an estimated $4.43M added.
  • The largest Fulcrum Therapeutics seller in Q2 2021 was Driehaus Capital Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2021.